Brint Family Translational Research Program (BFTRP)

The Brint Family Translational Research Program (BFTRP)  aims to accelerating preclinical translational research for inherited retinal degenerations (IRD) and dry age-related macular degeneration (dAMD). 

Current Research Priority Areas are:
- Novel Medical Therapies (NMT)
- Genetic Technologies (GT)
- Restorative Therapies (RT)

Funding: $1,000,000 total 
Duration: 3 years 

Research Authority due date: 1.6.26
​LOI (required) due date: 18.6.26
Full application due date: 22.10.26